MetLife (MET) Earnings Date & Reports

Key Takeaways

• Adjusted earnings per share (EPS) came in at $2.43, beating the consensus analyst estimate of approximately $2.30 and rising 20% year over year.
• Total revenue reached $19.15 billion, up 10.5% from a year ago but falling short of Wall Street expectations of roughly $19.5–$19.7 billion.
• Adjusted return on equity (ROE) — a measure of how efficiently the company generates profit from shareholder capital — hit 17%, landing at the top end of MetLife's 15%–17% target range for the second consecutive quarter.
• Group Benefits and Asia led segment growth, with adjusted earnings jumping 25% and 21% respectively, fueled by favorable underwriting and volume expansion.
• Shareholder returns exceeded $1.1 billion during the quarter through share repurchases and common stock dividends, reinforcing the company's capital-return commitment under its New Frontier strategy.
• After-hours trading showed a modest positive reaction, with shares edging up roughly 0.5% as investors weighed the earnings beat against the revenue shortfall.

Earnings Context and Why It Matters

MetLife's second-quarter 2026 results land at a pivotal moment for the global insurance industry. The company is in the second year of its "New Frontier" strategic plan, which targets double-digit adjusted EPS growth, an adjusted ROE of 15%–17%, and improved operational efficiency. After delivering a 23% adjusted EPS increase in the first quarter, expectations were elevated heading into this report. With the stock trading near its 52-week high of $97.80 and up more than 21% year to date — comfortably ahead of the broader market — investors were looking for confirmation that MetLife's diversified business model, spanning U.S. Group Benefits, Asia, Latin America, and asset management, can continue generating durable earnings growth even as industry conditions moderate.

Reported Results

MetLife reported net income of $705 million, or $1.09 per share, compared with $698 million, or $1.03 per share, in the same quarter last year. On an adjusted basis — which excludes net investment and derivative gains and losses as well as other items — earnings rose 15% to $1.57 billion, translating to $2.43 per share. That comfortably exceeded the consensus analyst estimate of roughly $2.30 per share.

Total revenue climbed 10.5% year over year to $19.15 billion, driven by a 7% increase in premiums, fees and other revenues (PFOs) to $13.65 billion and an 18% surge in net investment income to $6.7 billion. However, the top-line figure came in below the Street's forecast of approximately $19.5–$19.7 billion, partly reflecting lower-than-expected net premiums earned in certain segments.

On a segment basis, Group Benefits posted adjusted earnings of $503 million, up 25%, reflecting favorable life mortality trends and solid volume growth. Retirement and Income Solutions (RIS) delivered adjusted earnings of $377 million, a 2% increase, as higher variable investment income offset modest spread compression. Asia generated $420 million in adjusted earnings, up 21%, with strong contributions from Japan and Korea. Latin America rose 15% to $268 million, while EMEA (Europe, Middle East, and Africa) grew 8% to $108 million. MetLife Investment Management (MIM), which now includes the recently acquired PineBridge, contributed $57 million, up 6%.

Book value per share increased 8% year over year to $38.59, while adjusted book value per share — which excludes accumulated other comprehensive income (AOCI), meaning unrealized gains and losses that have not yet flowed through the income statement — rose 3% to $57.71.

AI Screener

For investors seeking to identify new opportunities in the insurance and financial services space, Tickeron's AI Screener offers a powerful AI-driven stock and ETF discovery tool. It enables traders and investors to filter thousands of securities using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and proprietary AI-generated signals. Whether you are scanning for breakout candidates, trending stocks, or fundamentally undervalued names, the AI Screener streamlines the research process and helps surface trade ideas more efficiently than traditional manual screening. Explore the platform to see how data-driven filtering can complement your earnings season analysis.

Market Reaction and Investor Sentiment

MetLife shares closed at $96.26 on August 5, near the upper end of their 52-week range, and edged about 0.5% higher in after-hours trading following the earnings release. The subdued but positive price action suggests that investors welcomed the strong bottom-line performance and margin discipline while acknowledging the revenue miss. Heading into the report, analyst sentiment was broadly constructive, with 12 of 18 analysts rating the stock a Buy and several firms — including JPMorgan, UBS, and Morgan Stanley — having recently raised their price targets to between $103 and $106. However, with EPS estimates having drifted lower by roughly 4% over the preceding 60 days and the stock trading near all-time highs, the results needed to validate elevated expectations. The earnings beat on the bottom line, combined with a second straight quarter of 17% adjusted ROE, appears to have done enough to sustain investor confidence in the near term.

Forward Outlook and Key Factors to Monitor

Looking ahead, MetLife's performance will depend on several interconnected factors that investors should monitor closely. The company's New Frontier strategy remains the central framework, with management targeting sustained double-digit adjusted EPS growth and an adjusted ROE within the 15%–17% range. Achieving these targets will require continued underwriting discipline across all operating segments, particularly in Group Benefits, where favorable mortality trends have been a meaningful tailwind but may not persist indefinitely.

Investment income trends are another key variable. MetLife reported net investment income of $6.7 billion in the second quarter, an 18% year-over-year increase, but variable investment income — which includes returns from private equity, real estate, and other alternative assets — came in at an estimated $220–$270 million for the quarter, below the implied quarterly run rate of the company's full-year guidance of approximately $1.6 billion. Should private equity and venture capital returns normalize further, this could create modest headwinds for future quarters.

International growth, particularly in Asia and Latin America, remains a critical pillar of the company's diversification. Asia delivered a 21% jump in adjusted earnings, driven by strong sales in Japan and Korea, while Latin America posted a 15% gain. Sustaining that momentum in the face of currency fluctuations and evolving regulatory environments — including ongoing discussions around insurance regulations in Japan — will be essential.

The integration of PineBridge into MetLife Investment Management is also worth watching. While MIM contributed positively in the second quarter, the business experienced institutional client outflows earlier in the year. The pace at which the combined platform stabilizes and begins capturing cross-selling opportunities, especially in private assets and international markets, will influence MIM's contribution to overall earnings over the next several quarters. Finally, capital management remains a bright spot: with over $1.1 billion returned to shareholders during the quarter and holding company liquidity at $3.4 billion, comfortably within the $3–$4 billion target range, MetLife retains significant flexibility to continue share buybacks and dividend payments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations